Author:
Biggs Catherine M.,Turvey Stuart E.
Reference27 articles.
1. Ailal F, Jouhadi Z, Jeddane L, Puel A, Picard C, Najib J, et al. About the first case of IRAK-4 deficiency in Morocco. J Clin Immunol. 2012;32:101.
2. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499–511.
3. Awane M, Andres PG, Li DJ, Reinecker HC. NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells. J Immunol. 1999;162(9):5337–44.
4. Chapel H, Puel A, von Bernuth H, Picard C, Casanova JL. Shigella sonnei meningitis due to interleukin-1 receptor-associated kinase-4 deficiency: first association with a primary immune deficiency. Clin Infect Dis. 2005;40(9):1227–31.
5. Deering RP, Orange JS. Development of a clinical assay to evaluate toll-like receptor function. Clin Vaccine Immunol. 2006;13(1):68–76.